Climb Bio Market Cap

Climb Bio has a market cap or net worth of $285.68 million as of October 25, 2024. Its market cap has increased by 293.49% in one year.

Market Cap

285.68M

Enterprise Value

62.64M

1-Year Change

293.49%

Ranking

#3373

Market Cap Chart

Since August 10, 2021, Climb Bio's market cap has decreased from $396.80M to $285.68M, a decrease of -28.00%. That is a compound annual growth rate of -9.73%.

Market Cap History

Date	Market Cap	% Change
Oct 25, 2024	285.70M	284.01%
Dec 29, 2023	74.40M	-23.69%
Dec 30, 2022	97.50M	-64.90%
Dec 31, 2021	277.80M	-29.99%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kamada	309.18M
Zura Bio	308.99M
Monte Rosa Therapeutics	308.68M
Inozyme Pharma	308.65M
Design Therapeutics	306.32M
Spok Holdings	303.72M
AC Immune	302.76M
Jasper Therapeutics	301.20M

Market Cap Rankings